Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Lamberts/ Re: dutton: we are raising our price target to $0.90 per share
2
Dec 11, 2007 05:17PM

Could you point the last one out to me? Outside of 10-Q's, I don't think I've seen any aggregate numbers since maybe July scanning these PR's.

Share
New Message
Please login to post a reply